Fluidigm Books Record Revenues in Q2; Cites Single-Cell Analysis, IP Pacts as Growth Drivers
August 11, 2011
Fluidigm Books Record Revenues in Q2; Cites Single-Cell Analysis, IP Pacts as Growth Drivers
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Fluidigm Developing Cellular Sample Prep Platform for Single-Cell Gene Expression, NGS Studies
May 17, 2012 / PCR Insider - Fluidigm Public Offering Provides Cash Reserve as it Seeks Potential Acquisition in Reagent Space
August 23, 2012 / PCR Insider - Report Sees Continued Growth for Fluidigm as Company Remains 'Interesting' Acquisition Target
May 31, 2012 / PCR Insider - As Novartis Prenatal Pact Ends, Fluidigm Offers IP to Others, Continues Single-Cell Genomics Push
May 10, 2012 / PCR Insider - Ambry Genetics to Offer Fluidigm-Based Genomic Research Services
April 12, 2012 / PCR Insider